Methamphetamine belongs in the class of stimulant drugs referred to as Amphetamine Type Stimulants (ATS). The category of ATS includes ecstasy, amphetamine and methamphetamine. This research project concerned itself with the amphetamine and methamphetamine class and excluded ecstasy (and henceforth we use the generic term methamphetamine). In Australia, methamphetamine is available in three forms—powder, base and crystal. Methamphetamine is associated with significant harms and is an important drug policy priority. The National Amphetamine-Type Stimulants Strategy (2008–2011) articulates the following priority areas in relation to methamphetamine: